Bevacizumab-Related Gastrointestinal Perforation in Hepatocellular Carcinoma Patient: A Case Report
This case highlights the importance of individualized perioperative management and careful timing of surgery following anti-VEGF therapy in HCC, emphasizing the role of multidisciplinary evaluation in the era of immunotherapy and targeted treatment.
Authors
- Guo‐Shiou Liao (ORCID: https://orcid.org/0000-0003-1082-679X)
- Kuo‐Feng Hsu (ORCID: https://orcid.org/0000-0001-9556-9221)
- Yi-Jie Wang
- Hsiu‐Lung Fan
Institutions
- National Defense Medical Center (TW)
Publication Details
- Journal
- Case Reports in Oncology
- Published
- 2025-12-18
- DOI
- https://doi.org/10.1159/000549176
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00